Abstract: Disclosed herein are methods of muscimol extraction from Amanita mushrooms, and more particularly, enhanced muscimol extraction processes from Amanita muscaria, including by distillation, refluxing, and pressing, including processes that increase muscimol content and decrease ibotenic acid content, and which provide liquid and powder extracts useful in preparations for human health.

Abstract: An example skin clarifier supplement including a synergistic combination of lobelia herb powder, plantain leaf powder, mullein leaf powder, ellecampane root powder and serrapeptase. Each component is provided in an effective dose to serve as an anti-inflammatory agent for treatment of skin conditions. In an example, the effective dose is about equal proportions by weight of the lobelia herb powder, the plantain leaf powder, the mullein leaf powder, the ellecampane root powder and the serrapeptase.

Abstract: A debittering Kudingcha extract, a preparation method and a fingerprint detection method thereof are disclosed, which relates to the technical field of extract preparation and detection. The extract is prepared from Kudingcha by enzymolysis, water extraction, concentration, drying, purification and enrichment by a macroporous resin column, and drying. When the macroporous resin column is arranged for purification and enrichment, it is first rinsed with pure water, and then eluted with an ethanol solution with volume fraction of 30-80%, and an ethanol eluent is collected. The Kudingcha extract is purified with macroporous resin, which can retain its effective ingredients to the greatest extent while reducing the bitter taste, and enhance the effect of improving energy and resisting fatigue. The quality control of products through fingerprint is conducive to the improvement of product stability and further promotion of products.

Abstract: Fagopyrum dibotyo nutraceuticals and methods of their use are provided. The disclosed F. dibotyo nutraceuticals are useful to improve or increase liver function and to treat liver diseases, especially those caused by viral hepatitis. In some embodiments, the F. dibotyo nutraceuticals also contain supplementary botanical extracts to confer additional health benefits.

Abstract: The present invention relates to an anti-inflammatory composition comprising Epimedium koreanum Nakai, Polygala tenuifolia Willd, and Polyporus umbellatus Fries extracts or a mixture thereof as an active ingredient. The extracts and mixture prepared according to the present invention exhibit a high inhibitory effect against nitric oxide and a suppressive effect against the expression of iNOS and COX2 and thus can be advantageously used as an anti-inflammatory composition.

Abstract: The present invention describes a gastro-resistant pharmaceutical/nutraceutical composition comprising chincona cortex freeze-dried (Cinchona succirubra), chicory leaves and roots freeze-dried (Cichorium intybus, and/or Cichorium endivia, and/or Cichorium pumilum, and/or Cichorium spinosum), and gentian root freeze-dried (Gentiana lutea), and optionally griffonia seed extract (Griffonia simplicifolia). The nutraceutical composition object of the present invention is useful for appetite control, mealtime energy intake reduction, and body weight loss.

Abstract: A composition containing Gardenia jasminoides-derived exosomes as an active ingredient is provided for skin elasticity improvement, skin wrinkle reduction, skin regeneration, skin tone improvement, skin brightness improvement, skin whitening, wound healing and/or wound healing acceleration.

Abstract: A method for inhibiting skin damage caused by blue light, reducing skin sagging, reducing skin porphyrin content, or increasing ferritin content in a subject in need thereof is provided. The method includes: administering to the subject an effective dose of queen plum extract. The queen plum extract is obtained by extracting whole fruit of Prunus salicina by water. The queen plum extract has at least one of the following effects: inhibiting skin damage caused by blue light, improving skin sagging, reducing skin porphyrin content or increasing ferritin content.

Abstract: Provided is composition for preventing and treating depression, including complex extracts of Zizyphi spinosi Semen, Jujubae Fructus, Hordei Fructus Germinatus, Glycyrrhizae Radix et Rhizoma, Angelicae Gigantis Radix, and Beta vulgaris as active ingredients. The complex extracts including Zizyphi spinosi Semen, Jujubae Fructus, Hordei Fructus Germinatus, Glycyrrhizae Radix et Rhizoma, Angelicae Gigantis Radix, and Beta vulgaris have an antidepressant effect and an effect on the expression of proteins related to antidepressant action. The complex extracts of the present disclosure may be effectively used as a composition for preventing and treating depression.

Abstract: The present invention relates to a composition for treating damaged skin, the composition comprising a synergistic mixture of: (a) from about 0.1 to about 5% by weight of Padina pavonica extract; (b) from about 0.1 to about 5% by weight of Scutellaria baicalensis extract; (c) from about 0.1 to about 5% by weight of Physalis angulata extract; and (d) from about 1 to about 5% by weight of an emulsifier, all weights based on the total weight of the composition.

Abstract: Disclosed is a method of treating a skin condition. The method can include topically applying to skin having the skin condition a composition comprising an effective amount of an extract of Khaya senegalensis to treat the skin condition.

Abstract: A prebiotic composition includes a black tea ferment and a bioactive substance. The bioactive substance is soybean peptide powder, pea protein, rice protein, corn oligopeptide powder, or a combination thereof. The black tea ferment is prepared by the following steps: extracting tea leaves of Camellia sinensis with water at 50° C. to 100° C. for 0.5 hours to 3 hours to obtain a black tea extract, and fermenting the black tea extract with Saccharomyces cerevisiae BCRC20271, Bifidobacterium lactis BCRC910887, Lactobacillus gasseri BCRC910886, and Gluconacetobacter xylinus BCRC12335 for 12 days to 25 days to obtain the black tea ferment.

Abstract: A medicine for topical wound treatment relates to the field of pharmaceutical technology. A plant composition incudes tea leaves, lotus leaves, Galla chinensis, Stevia rebaudiana, Cyclocarya paliurus, Gynura divaricata, Taraxacum mongolicum and Solanum lycopersicum. The medicine for topical wound treatment can promote the rapid repair of diabetic foot ulcers (DFUs) and reduce the damage of the DFUs to human health by controlling the local blood glucose, local infection, microvascular injury, inflammatory reaction, peripheral nerve injury, coagulation-hemolysis dysfunction of the DFUs.

Abstract: Methods for prevention and reversal of inflammation.

Abstract: The present invention provides a pharmaceutical composition for the treatment of obesity and fatty liver disease caused due to a high-fat diet, containing, as an active ingredient, the powder of a fruiting body or a mycelium of hybrid mushroom strain GBN2WP0970 having no side effects and an excellent triglyceride absorption inhibitory effect.

Abstract: The present invention relates to a composition comprising Cricket or an extract thereof for improving a bowel movement function or weight loss.

Abstract: An areca nut product and preparation method thereof, and an areca nut additive agent are provided. The areca nut product is prepared from areca nuts, citric acid, mature vinegar, chitosan, active zinc oxide, monazite calcined distilled water, bovine bone protein peptide, lipase, isomaltooligosaccharide, soybean lecithin, ginseng, atractylodes macrocephala, poria cocos, liquorice, astragalus, notoginseng, tangerine peel, folium eucommiae, citronella grass, and mucor. Experimental tests shows that the areca nut product of the disclosure has a good antiviral effect, and the areca nut product has good preventive and therapeutic effects on oral diseases; compared with ordinary areca nut products, carcinogenic study has shown that carcinogenicity of the areca nut product of the disclosure has significantly reduced.

Abstract: The object of the invention is a method for extracting, with high yield, phycobiliproteins from cyanobacterial and/or algal biomass, obtaining extracts in water or aqueous solutions characterised by high pigment concentration and a purity degree equal to or greater than the food/cosmetic grade (P?2). The method is based on a process characterised by a step of breaking down the cyanobacterial/algal cells by ultrasonication in an aqueous solution of ammonium sulphate, and simultaneous extraction of water-soluble compounds other than phycobiliproteins, followed by an extraction step of the phycobiliproteins using water or aqueous solutions.

Abstract: A method for preparing ginseng extract rich in rare ginsenosides is disclosed. Ginseng roots or ginseng stems and leaves are extracted, enzymatically hydrolyzed and treated with high temperature and high pressure. The preparation method can quickly and effectively increase the proportion of rare ginsenosides in the ginseng extract. After in vitro antioxidant experiments and in vivo experiments with Hidradenitis elegans nematode, the extract and related complexes were proved to be effective in antioxidant, anti-oxidative stress, and improving age-related muscle decline and other dysfunctions. After genetic and metabolomic studies, the anti-aging mechanism was proved to be related to the expression of genes associated with nutrient sensing, stress-related pathways and redox processes, and showed innate immune response and redox process GO enrichment, proving its oxidative stress resistance.

Abstract: An insoluble cell fraction obtained from plant cells cultured in a suspension composed entirely of natural molecules for the treatment of primary and recurrent Clostridium difficile infections is provided. A process for the preparation of the insoluble cell fraction is also provided.